Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: Effects on maternal and child outcomes

American Journal of Clinical Nutrition

Volumn 87, Issue 6, 2008, Pages 1802-1808

  Kupka, Roland ^a   Mugusi, Ferdinand ^b   Aboud, Said ^b   Msamanga, Gernard I ^b   Finkelstein, Julia L ^a   Spiegelman, Donna ^a   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; IRON; MULTIVITAMIN; PLACEBO; SELENOMETHIONINE;

ADULT; ARTICLE; BIRTH WEIGHT; CD4+ T LYMPHOCYTE; CHILDHOOD MORTALITY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON THERAPY; MATERNAL MORBIDITY; MATERNAL MORTALITY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SMALL FOR DATE INFANT; SURVIVAL; TANZANIA; VIRUS LOAD; VITAMIN SUPPLEMENTATION;

EID: 45749143875     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/87.6.1802     Document Type: Article

References (44)

1. UNAIDS. AIDS Epidemic Update. Geneva, Switzerland: UNAIDS, 2007.
2. WHO/UNAIDS/UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report, April 2007. Geneva, Switzerland: UNAIDS, 2007.
3. Foster H. AIDS and the "selenium-CD4 T cell tailspin". The geography of a pandemic. Townsend Letter for Doctors & Patients 2000;94-99.
4. Kupka R, Msamanga GI, Spiegelman D, et al. Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 2004;134:2556-60.
5. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr 1997;15:370-4.
6. Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr 1999;20:508-13.
7. Constans J, Pellegrin JL, Sergeant C, et al. Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:392.
8. Hurwitz BE, Klaus JR, Llabre MM, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 2007;167:148-54.
9. Flohe L. Glutathione peroxidase. Basic Life Sci 1988;49:663-8.
10. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann NY Acad Sci 1990;587:123-39.
11. Abrams EJ, Matheson PB, Thomas PA, et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group. Pediatrics 1995;96:451-8.
12. Gray RH, Wawer MJ, Serwadda D, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998;351:98-103.
13. Kupka R, Garland M, Msamanga G, Spiegelman D, Hunter D, Fawzi W. Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2005;39:203-10.
14. Drain PK, Baeten JM, Overbaugh J, et al. Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis 2006;6:85.
15. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006;367:1521-32.
16. Food and Nutrition Board. DRI: dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000.
17. Raboud JM, Montaner JS, Conway B, et al. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J Infect Dis 1996;174:191-4.
18. Paxton WB, Coombs RW, McElrath MJ, et al. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virusinfected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis 1997;175:247-54.
19. Brambilla D, Reichelderfer PS, Bremer JW, et al. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program. AIDS 1999;13:2269-79.
20. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351:1477-82.
21. Hughes MD, Pocock SJ. Interim monitoring of clinical trials. In: Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. Hoboken, NJ: Wiley & Sons, 1995;177-196.
22. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of mother-tochild transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
23. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
24. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162:199-200.
25. Burbano X, Miguez-Burbano MJ, McCollister K, et al. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials 2002;3:483-91.
26. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 1994;41:103-14.
27. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994;41:115-27.
28. Broome CS, McArdle F, Kyle JA, et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 2004;80:154-62.
29. Delmas-Beauvieux MC, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene [published erratum appears in Am J Clin Nutr 1996 Dec;64(6):971]. Am J Clin Nutr 1996;64:101-7.
30. Stephensen CB, Marquis GS, Douglas SD, Kruzich LA, Wilson CM. Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr 2007;85:173-81.
31. Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 1990;87:9943-7.
32. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-58.
33. Barrington JW, Lindsay P, James D, Smith S, Roberts A. Selenium deficiency and miscarriage: a possible link? Br J Obstet Gynaecol 1996;103:130-2.
34. Ursini F, Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 1987;44:255-76.
35. Cengiz B, Soylemez F, Ozturk E, Cavdar AO. Serum zinc, selenium, copper, and lead levels in women with second-trimester induced abortion resulting from neural tube defects: a preliminary study. Biol Trace Elem Res 2004;97:225-35.
36. Villamor E, Msamanga G, Spiegelman D, Peterson KE, Antelman G, Fawzi WW. Pattern and predictors of weight gain during pregnancy among HIV-1-infected women from Tanzania. J Acquir Immune Defic Syndr 2003;32:560-9.
37. Hawker FH, Stewart PM, Snitch PJ. Effects of acute illness on selenium homeostasis. Crit Care Med 1990;18:442-6.
38. Nichol C, Herdman J, Sattar N, et al. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clin Chem 1998;44:1764-6.
39. Zugner A. Selenium: great claims, few data. AIDS Clinical Care 2007;1-1.
40. Ross DA, Cousens S, Wedner SH, Sismanidis C. Does selenium supplementation slow progression of HIV? Potentially misleading presentation of the results of a trial. Arch Intern Med 2007;167:1555-6; author reply 1557.
41. Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr 2005;59:1250-8.
42. Lee AM, Huel G, Godin J, et al. Inter-individual variation of selenium in maternal plasma, cord plasma and placenta. Sci Total Environ 1995;159:119-27.
43. Kumpulainen J, Salmenpera L, Siimes MA, Koivistoinen P, Perheentupa J. Selenium status of exclusively breast-fed infants as influenced by maternal organic or inorganic selenium supplementation. Am J Clin Nutr 1985;42:829-35.
44. Neve J. New approaches to assess selenium status and requirement. Nutr Rev 2000;58:363-9.